Alerts will be sent to your verified email
Verify Email
SOTAC
|
Sotac Pharmaceutical
|
Zenith Drugs
|
Murae Organisor
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-4.85 % | 22.97 % | 5.64 % |
|
5yr average Equity Multiplier
|
7.05 | 4.46 | 2.09 |
|
5yr Average Asset Turnover Ratio
|
1.3 | 1.16 | 0.81 |
|
5yr Avg Net Profit Margin
|
1.45 % | 4.99 % | 5.31 % |
|
Price to Book
|
0.0 | 0.0 | 0.54 |
|
P/E
|
14.88 | 12.14 | 7.4 |
|
5yr Avg Cash Conversion Cycle
|
3.3 Days | -99.3 Days | 16.76 Days |
|
Inventory Days
|
36.47 Days | 53.1 Days | 424.86 Days |
|
Days Receivable
|
72.11 Days | 141.66 Days | 56.13 Days |
|
Days Payable
|
136.32 Days | 298.39 Days | 12.67 Days |
|
5yr Average Interest Coverage Ratio
|
3.3 | 4.04 | 538.35 |
|
5yr Avg ROCE
|
19.17 % | 30.01 % | 8.92 % |
|
5yr Avg Operating Profit Margin
|
7.12 % | 9.39 % | -8.27 % |
|
5 yr average Debt to Equity
|
2.81 | 1.14 | 0.56 |
|
5yr CAGR Net Profit
|
116.49 % | 25.02 % | 142.32 % |
|
5yr Average Return on Assets
|
1.93 % | 5.56 % | 3.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.85 % | 69.98 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -37.57 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sotac Pharmaceutical
|
Zenith Drugs
|
Murae Organisor
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|